Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Using 3D Invasion properties of RCC Cell Lines In Vitro to predict their Metastatic Potential In Vivo.

Cell death discovery·2026
Same author

Discovery of a novel, selective CK2 inhibitor class with an unusual basic scaffold.

European journal of medicinal chemistry·2024
Same author

New players in the landscape of renal cell carcinoma bone metastasis and therapeutic opportunities.

International journal of cancer·2024
Same author

Author Correction: GIMAP5 deficiency reveals a mammalian ceramide-driven longevity assurance pathway.

Nature immunology·2024
Same author

Cancer selective cell death induction by a bivalent CK2 inhibitor targeting the ATP site and the allosteric αD pocket.

iScience·2024
Same author

GIMAP5 deficiency reveals a mammalian ceramide-driven longevity assurance pathway.

Nature immunology·2024

Related Experiment Video

Updated: Jun 2, 2026

Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death
09:18

Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death

Published on: December 27, 2016

Protein kinases curb cell death.

Odile Filhol1, Claude Cochet

  • 1INSERM, Unité 1036, Biology of Cancer and Infection, Grenoble, F-38054, France.

Science Signaling
|May 12, 2011
PubMed
Summary

Protein kinase CK2 globally inhibits programmed cell death by phosphorylating caspases and their substrates. This kinase activity, dysregulated in cancer, contributes to tumorigenesis by suppressing apoptosis.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Oncology

Background:

  • Caspases are key executioners of programmed cell death (apoptosis).
  • Protein kinases can phosphorylate caspases and their substrates, suggesting pathway crosstalk.
  • Phosphorylation can inhibit caspase activity by preventing substrate cleavage.

Purpose of the Study:

  • To identify the primary kinase involved in regulating caspase signaling.
  • To investigate the role of this kinase in cancer development.

Main Methods:

  • Literature review and analysis of existing studies on kinase-substrate interactions and caspase signaling.
  • Examination of protein kinase CK2's role in cellular signaling networks.

Main Results:

More Related Videos

LPS and ATP-induced Death of PMA-differentiated THP-1 Macrophages and its Validation
06:12

LPS and ATP-induced Death of PMA-differentiated THP-1 Macrophages and its Validation

Published on: May 3, 2024

Identification of Novel CK2 Kinase Substrates Using a Versatile Biochemical Approach
11:11

Identification of Novel CK2 Kinase Substrates Using a Versatile Biochemical Approach

Published on: February 21, 2019

Related Experiment Videos

Last Updated: Jun 2, 2026

Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death
09:18

Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death

Published on: December 27, 2016

LPS and ATP-induced Death of PMA-differentiated THP-1 Macrophages and its Validation
06:12

LPS and ATP-induced Death of PMA-differentiated THP-1 Macrophages and its Validation

Published on: May 3, 2024

Identification of Novel CK2 Kinase Substrates Using a Versatile Biochemical Approach
11:11

Identification of Novel CK2 Kinase Substrates Using a Versatile Biochemical Approach

Published on: February 21, 2019

  • Protein kinase CK2 was identified as a prominent kinase globally inhibiting caspase signaling.
  • CK2 phosphorylates caspases and their substrates, protecting them from cleavage.
  • CK2 dysregulation is implicated in various cancers, promoting cell growth and inhibiting apoptosis.

Conclusions:

  • Protein kinase CK2's ability to inhibit caspase activity contributes to its oncogenic potential.
  • CK2's role in suppressing apoptosis is a key mechanism in tumorigenesis.